GSK Supply Information
GSK will continue the supply of ceftazidime within our warehouse (including 3rd party stock) until all stock is exhausted. Please review the below information to ensure your ordering systems are updated to remove the discontinued GSK SKUs from future orders.
Update: Please note we have sold through all stock of (Multichem) m-Cefuroxime 750mg injection (5x750mg vials). PHARMAC has advised that stock of the Actavis brand of cefuroxime 1.5g and 750mg is expected to be available by 20 November. This brand was listed in the Schedule from 1 November 2017.